Ritlecitinib for Cicatricial Alopecia | MicrobiomeTrials← Back to trialsNCT05549934
Ritlecitinib for Cicatricial Alopecia
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-12-15Est. Completion: 2025-03-20
Enrollment target: 50 participants Locations- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Other microbiome trials you might be interested in
Central Centrifugal Cicatricial AlopeciaFrontal Fibrosing Alopecia
This is a prospective, open-label clinical trial, in which all participants will be treated with deucravacitinib for 48 …
New York, United StatesEst. completion Jun 30, 2028
Central Centrifugal Cicatricial AlopeciaLichen Planopilaris
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adu…
New York, United StatesEst. completion Apr 5, 2027